دورية أكاديمية

Efficacy and safety of anti-interleukin-1 therapeutics in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials

التفاصيل البيبلوغرافية
العنوان: Efficacy and safety of anti-interleukin-1 therapeutics in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials
المؤلفون: Lizhi Yu, Raoshan Luo, Gang Qin, Qinyan Zhang, Weiming Liang
المصدر: Journal of Orthopaedic Surgery and Research, Vol 18, Iss 1, Pp 1-16 (2023)
بيانات النشر: BMC, 2023.
سنة النشر: 2023
المجموعة: LCC:Orthopedic surgery
LCC:Diseases of the musculoskeletal system
مصطلحات موضوعية: Anti-interleukin-1 therapeutics, Meta-analysis, IL-1 antibodies, Interleukin-1 receptor antagonist, IL-1 inhibitors, Orthopedic surgery, RD701-811, Diseases of the musculoskeletal system, RC925-935
الوصف: Abstract Objective We aimed to evaluate the efficacy and safety of anti-interleukin-1 therapeutics, including IL-1 antibodies, interleukin-1 receptor antagonists (IL-1 Ras) and IL-1 inhibitors, for knee osteoarthritis (KOA) treatment. Methods Databases (Medline, Embase, Web of Science and CENTRAL) and ClinicalTrials.gov were systematically searched for randomized controlled trials (RCTs) of anti-interleukin-1 therapeutics from inception to August 31, 2022. The outcomes were the mean change in pain and function scores and the risk of adverse effects (AEs). Results In the 12 studies included, anti-interleukin-1 therapeutics were superior to placebo in terms of pain relief (standardized mean difference [SMD] = − 0.38, 95% confidence interval [CI] = − 1.82 to − 0.40, p
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1749-799X
العلاقة: https://doaj.org/toc/1749-799XTest
DOI: 10.1186/s13018-023-03590-2
الوصول الحر: https://doaj.org/article/4fe2cf67cc8640d1a844a53508679fb4Test
رقم الانضمام: edsdoj.4fe2cf67cc8640d1a844a53508679fb4
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:1749799X
DOI:10.1186/s13018-023-03590-2